Retinoic acid enhanced human stem cell derived blood brain barrier model
AssigneeWisconsin Alumni Research Foundation
InventorsEric V. Shusta, Sean P. Palecek, Ethan S. Lippmann, Samira M. Azarin
Life of this patent
Estimating the term…
Loading patent…
AssigneeWisconsin Alumni Research Foundation
InventorsEric V. Shusta, Sean P. Palecek, Ethan S. Lippmann, Samira M. Azarin
Estimating the term…
In one embodiment, the present invention is a method of creating a fully-human blood-brain barrier (BBB) model, comprising the steps of (a) obtaining a mixture of neural cells and brain microvascular endothelial cells (BMECs), wherein the neural cells and BMECs that comprise the mixture were produced from the differentiation of human pluripotent stem cells (hPSCs); (b) purifying BMECs from the mixture of neural cells and BMECs of step (a); and (c) co-culturing the purified BMECs with a cell type selected from the group consisting of pericytes, astrocytes and differentiated neural progenitor cells (NPCs), wherein a blood brain barrier model is created.
A method of creating a retinoic acid (RA)-enhanced fully-human blood-brain barrier (BBB), wherein the transendothelial electrical resistance (TEER) of the BBB formed is greater than 4000 Ohm×cm2 in an optimized endothelial cell medium (OECM) wherein the OECM does not contain basic fibroblast growth factor (bFGF), the method comprising the steps of:
Dependencies are inferred from the claim text.